发明公开
EP2581083A1 Methods of treating hematologic cancers using pnp inhibitors such as forodesine in combination with alkylating agents or anti-cd20 agents
审中-公开
与烷化剂或抗CD20剂一起用于血液的癌症的治疗的方法，通过PNP抑制剂例如Forodesin的手段
- 专利标题： Methods of treating hematologic cancers using pnp inhibitors such as forodesine in combination with alkylating agents or anti-cd20 agents
- 专利标题（中）： 与烷化剂或抗CD20剂一起用于血液的癌症的治疗的方法，通过PNP抑制剂例如Forodesin的手段
-
申请号： EP12196293.0申请日： 2008-12-10
-
公开(公告)号： EP2581083A1公开(公告)日： 2013-04-17
- 发明人: Bantia, Shanta , Breitfeld, Philip , Babu, Yarlagadda Sudhakara
- 申请人： Biocryst Pharmaceuticals, Inc.
- 申请人地址： 4505 Emperor Blvd. Durham, North Carolina 27703 US
- 专利权人： Biocryst Pharmaceuticals, Inc.
- 当前专利权人： Biocryst Pharmaceuticals, Inc.
- 当前专利权人地址： 4505 Emperor Blvd. Durham, North Carolina 27703 US
- 代理机构： Office Freylinger
- 优先权： US12762P 20071210
- 主分类号： A61K31/4184
- IPC分类号： A61K31/4184 ; A61K31/4745 ; A61K39/395 ; A61K45/06 ; A61P35/02
摘要：
The present application relates to treatment of hematologic cancers, which treatments can include, e.g., administration of a purine nucleoside phosphorylase (PNP) inhibitor, an alkylating agent and/or an anti-CD20 agent, and related compositions and kits.
信息查询
IPC分类:
